Why choose CSL Behring?

At CSL Behring, we partner with you to ensure your ongoing success.

But don’t just take our word for it—see what some of our customers have said:

A History of "Firsts"
We take responsibility for our HSA from plasma collection
to product release

At CSL Behring, we’re dedicated to meeting or exceeding the most stringent international standards for plasma‑product safety in accordance with guidelines from worldwide regulatory agencies. Our dedication to collecting safe plasma and producing the highest quality products via CSL’s Integrated Safety System is well known in the industry and includes:

  • CSL Behring-owned collection centers
  • Strict donor selection and donor screening
  • Extensive plasma testing and inventory hold before release for manufacturing
    – 5-NAT/PCR testing
  • CSL Behring-owned fractionation manufacturing facilities
  • Proven virus inactivation and removal in the HSA manufacturing process
  • Pharmacovigilance
Safety and Quality
  • Single donations, mini pools and final product are tested for the detection of human pathogenic viruses.
  • Mandatory serologic and laboratory screens are carried out on donated plasma including tests for HIV-1, HIV-2, hepatitis B and C and parvovirus B19, in addition, liver function tests are performed.
  • During more than a 50 year history* of marketing CSL Behring Albumin, there is no case of transmission of viral disease or CJD3.

3. CSL Behring pharmacovigilance, data on file.